Conversion of Loan Notes

Paris, France and Camberley, UK – 27 September 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) an international specialist in clinical diagnostics, announces that, pursuant to the Convertible Bonds with Warrants Funding Programme announced on 26 April 2019, it has issued a tranche of new ordinary shares of €1/15 each (“Ordinary Shares”) to Negma Group Limited following the receipt of conversion notices. Further details are set out below.

http://novacyt.com/wp-content/uploads/2019/10/26.-Novacyt-Note-Conversion-26-27.09.19-ENGLISH.pdf